Selected Publications
  • D.J. Lodge, M.M. Behrens & A.A. Grace. (2009) A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. Journal of Neuroscience 29:5419-08.
  • D.J. Lodge & A.A. Grace. (2008) Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: A mechanism of behavioral sensitization. Journal of Neuroscience 28:7876-82.
Daniel Lodge

Daniel Lodge

Assistant Professor of Pharmacology

Office: 210-567-4188


View video introduction to Dr. Lodge's lab



dopamine, hippocampus, schizophrenia, drug abuse, electrophysiology, neuroscience


Research Summary

The mesolimbic dopamine system regulates the cognitive, motivational and behavioral processes critical to normal functioning. Dysfunction in this system has been linked to a number of psychiatric disorders including schizophrenia and drug abuse. Our research centers around how the mesolimbic dopamine system is regulated by afferent structures, such as the ventral hippocampus. We combine in vivo electrophysiology with activation and/or inactivation of afferent structures to examine how these pathways interact to control dopamine neuron output. To complement this systems-oriented approach, behavioral and neurochemical methods are employed to provide an important correlate for changes observed at the cellular level. Using such an approach, we hope to provide a better understanding into how disturbances in the control of dopamine neuron activity may contribute to psychiatric disorders.

• Lab Personnel •

Dr. Jennifer Donegan - Postdoctoral Fellow

Dr. Stephanie Perez - Postdoctoral Fellow

Angela Boley - Research Assistant

David Aguilar - Graduate Student

Jordan Thomas - START-UP Student